Merck & Company Inc
This page as JSON
GET /v2/symbols/MRKGet a free API key ↗| 24 hours | 7 days | Whole window | |
|---|---|---|---|
| Statements | 15 | 49 | 103 |
| Stories | 7 | 23 | 53 |
| Outlets | 10 | 29 | 40 |
| ▲ Bullish | 8 | 14 | 37 |
| ▼ Bearish | 0 | 7 | 15 |
| ● Neutral | 7 | 28 | 51 |
Coverage, day by day
Tone of the statements
All 49 statements naming Merck & Company Inc, last 7 days
▲ 14 ▼ 7 ● 28
36 that name only Merck & Company Inc
▲ 10 ▼ 5 ● 21
A statement that also names others may not be about Merck & Company Inc; the second bar counts only those that name it alone. Tone is a label on each statement. It describes the news, not a price.
Latest statements
Merck & Co stock rose two percent on US stock market opening.
Merck & Co reported strong third-quarter results and raised its full-year guidance.
Merck reports a per-share adjusted net income of $2.49 for the third quarter of 2026.
Moderna and Merck Pharma investors are in conflict with oncologists regarding cancer drugs.
Merck's Keytruda injectable form demonstrated stronger-than-expected sales.
5 of 103 statements shown. The API returns all of them: GET /v2/statements?symbol=MRK Get a free API key ↗